GC Genome Corporation (KOSDAQ:340450)
7,400.00
-500.00 (-6.33%)
At close: Mar 23, 2026
| Market Cap | 175.02B |
| Revenue (ttm) | 31.53B +21.8% |
| Net Income | 4.04B |
| EPS | 185.00 |
| Shares Out | 23.65M |
| PE Ratio | 40.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 181,684 |
| Average Volume | 278,289 |
| Open | 7,690.00 |
| Previous Close | 7,900.00 |
| Day's Range | 7,150.00 - 7,690.00 |
| 52-Week Range | 6,200.00 - 15,180.00 |
| Beta | n/a |
| RSI | 44.23 |
| Earnings Date | Apr 3, 2026 |